Literature DB >> 2443497

Calcium-dependent interaction between the epidermal growth factor precursor-like region of human protein C and a monoclonal antibody.

A K Ohlin1, J Stenflo.   

Abstract

Protein C, like the other vitamin K-dependent plasma proteins that participate in blood coagulation, except prothrombin, has at least one high affinity calcium-binding site that is independent of gamma-carboxyglutamic acid. Calcium binding to this site is required for activation of protein C by the thrombin-thrombomodulin complex. In an attempt to localize this calcium-binding site, we subjected protein C to limited tryptic digestion. A monoclonal antibody that recognizes a calcium-dependent epitope both in intact protein C, in gamma-carboxyglutamic acid-domainless protein C, and in activated protein C, was used to isolate a fragment from the tryptic digest. The fragment was derived from the light chain of protein C and consisted of the two domains that are homologous to the epidermal growth factor precursor. Half-maximal binding of the intact protein and of the isolated fragment by the antibody occurred at 100-200 microM Ca2+. The results suggest the presence of a Ca2+-binding site in the epidermal growth factor homology region of protein C.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2443497

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  The molecular genetics of Marfan syndrome and related microfibrillopathies.

Authors:  P N Robinson; M Godfrey
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

2.  Isolation and functional characterization of the proenzyme form of the catalytic domains of human C1r.

Authors:  M B Lacroix; C A Aude; G J Arlaud; M G Colomb
Journal:  Biochem J       Date:  1989-02-01       Impact factor: 3.857

3.  Calcium binding to tandem repeats of EGF-like modules. Expression and characterization of the EGF-like modules of human Notch-1 implicated in receptor-ligand interactions.

Authors:  M D Rand; A Lindblom; J Carlson; B O Villoutreix; J Stenflo
Journal:  Protein Sci       Date:  1997-10       Impact factor: 6.725

4.  Direct detection of point mutations by mismatch analysis: application to haemophilia B.

Authors:  A J Montandon; P M Green; F Giannelli; D R Bentley
Journal:  Nucleic Acids Res       Date:  1989-05-11       Impact factor: 16.971

5.  Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.

Authors:  N M Thielens; C Illy; I M Bally; G J Arlaud
Journal:  Biochem J       Date:  1994-07-15       Impact factor: 3.857

6.  Hydroxylation of aspartic acid in domains homologous to the epidermal growth factor precursor is catalyzed by a 2-oxoglutarate-dependent dioxygenase.

Authors:  J Stenflo; E Holme; S Lindstedt; N Chandramouli; L H Huang; J P Tam; R B Merrifield
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

7.  The first EGF-like domain from human factor IX contains a high-affinity calcium binding site.

Authors:  P A Handford; M Baron; M Mayhew; A Willis; T Beesley; G G Brownlee; I D Campbell
Journal:  EMBO J       Date:  1990-02       Impact factor: 11.598

8.  Recombinant human protein C derivatives: altered response to calcium resulting in enhanced activation by thrombin.

Authors:  H J Ehrlich; B W Grinnell; S R Jaskunas; C T Esmon; S B Yan; N U Bang
Journal:  EMBO J       Date:  1990-08       Impact factor: 11.598

9.  Disulfides modulate RGD-inhibitable cell adhesive activity of thrombospondin.

Authors:  X Sun; K Skorstengaard; D F Mosher
Journal:  J Cell Biol       Date:  1992-08       Impact factor: 10.539

10.  Calcium-dependent antigen binding as a novel modality for antibody recycling by endosomal antigen dissociation.

Authors:  N Hironiwa; S Ishii; S Kadono; Y Iwayanagi; F Mimoto; K Habu; T Igawa; K Hattori
Journal:  MAbs       Date:  2015-10-23       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.